Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07525544) titled 'A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants' on April 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: ViiV Healthcare
Condition:
HIV Infections
Intervention:
Drug: VH4770359
Drug: Placebo
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: April 7, 2026
Target Sample Size: 214
To know more, visit https://clinicaltrials.gov/study/NCT07525544
Published by HT Digital Content Servic...